-
公开(公告)号:AU725164B2
公开(公告)日:2000-10-05
申请号:AU6124196
申请日:1996-06-03
Applicant: BASF AG
Inventor: HAUPT ANDREAS , EMLING FRANZ , ROMERDAHL CYNTHIA A
Abstract: Novel compounds of the formulaR1R2N-CHX-CO-A-B-D-(E)s-(F)t-(G)U-KIin which R1, R2, A, B, D, E, F, G, K, X, s, t, and u have the meanings stated in the description, and the preparation thereof are described. The novel substances have an antineoplastic effect.
-
192.
公开(公告)号:CO4950525A1
公开(公告)日:2000-09-01
申请号:CO98012757
申请日:1998-03-09
Applicant: BASF AG
Inventor: RITTER KURT , AMBERG WILHELM , BARLOZZARI TERESA , HAUPT ANDREAS , JANSSEN BERND , KLING ANDREAS
Abstract: Un compuesto, CARACTERIZADO PORQUE presenta la siguientefórmula general A-B-D-E-F-G, donde A, B, D y E son, cada uno, un residuo de un a-aminoácido; F es un residuo del ácido azacicloalcancarboxílico y G es un radical monovalente seleccionado del grupo formado por hidrógeno, alquilo, cicloalquilo, cicloalquilalquilo, amincarbonilalquilo, arilalquilo, alcoxicarbonilalquilo, ariloxicarbonilalquilo, alquilsulfinilalquilo, alquilsulfonilalquilo, arilsulfinilalquilo, arilsulfonilalquilo, alquil- o arilsulfinilo y alquil- o arilsulfonilo; o F es un grupo azacicloalquilo y G es un grupo heteroarilo; o una sal ácido de los mismos. El compuesto de la cláusula 1, CARACTERIZADO PORQUE el ácido es seleccionado del grupo formado por: ácido clorhídrico, ácido cítrico, ácido tartárico, ácido láctico, ácido fosfórico, ácido metansulfónico, ácido acético, ácido fórmico, ácido maléico, ácido fumárico, ácido málico, ácido succínico, ácido malónico, ácido sulfúrico, ácido L- glutámico, ácido L-aspártico, ácido pirúvico, ácido múcico, ácido benzóico, ácido glucurónico, ácido oxálico, ácido ascórbico o N-acetilglicina. El compuesto de la cláusula 1, CARACTERIZADO PORQUE A es un derivado de prolina de Fórmula IIa, na es 0, 1, 2 ó 9 3; Ra es un átomo de hidrógeno o un grupo metilo, etilo, propilo normal, isopropilo o ciclopropilo no sustituido o sustituido con flúor, R1 a es un átomo de hidrógeno o un grupo metilo, etilo, propilo, fenilo o grupo fenilo sustituido, donde los sustituyentes de fenilo comprenden uno o más grupos alquilo, alcoxi, trifluorometilo o ...
-
公开(公告)号:BR9810911A
公开(公告)日:2000-08-01
申请号:BR9810911
申请日:1998-07-07
Applicant: BASF AG
Inventor: JANSSEN BERND , BARLOZZARI TERESA , HAUPT ANDREAS , ZIERKE THOMAS , KLING ANDREAS
Abstract: Compounds of the present invention include cell growth inhibitors which are peptides of Formula I, A-B-D-E-F-(G)r-(K)s-L (I), and acid salts thereof, wherein A, B, D, E, F, G and K are α-amino acid residues, and s and r are each, independently, 0 or 1. L is a monovalent radical, such as, for example, an amino group, an N-substituted amino group, a &bgr;-hydroxylamino group, a hydrazido group, an alkoxy group, a thioalkoxy group, an aminoxy group, or an oximato group. The present invention also includes a method for treating cancer in a mammal, such as a human, comprising administering to the mammal an effective amount of a compound of Formula I in a pharmaceutically acceptable composition.
-
公开(公告)号:PL178766B1
公开(公告)日:2000-06-30
申请号:PL30935393
申请日:1993-12-04
Applicant: BASF AG
Inventor: HAUPT ANDREAS , JANSSEN BERND , RITTER KURT , KLINGE DAGMAR , KEILHAUER GERHARD , ROMERDAHL CYNTHIA , BARLOZZARI TERESA , QIAN XIAO-DONG
-
公开(公告)号:NO20001758A
公开(公告)日:2000-06-05
申请号:NO20001758
申请日:2000-04-05
Applicant: BASF AG
Inventor: BARLOZZARI TERESA , BANERJEE SUBHASHIS , HAUPT ANDREAS
CPC classification number: A61K38/08 , A61K39/395 , A61K2300/00
-
公开(公告)号:PL335579A1
公开(公告)日:2000-05-08
申请号:PL33557998
申请日:1998-03-09
Applicant: BASF AG
Inventor: BARLOZZARI TERESA , HAUPT ANDREAS
IPC: A61K31/337 , A61K38/00 , A61K38/07 , A61K38/08 , A61K38/15 , A61P35/00 , C07K5/08 , C07K5/10 , C07K7/00 , A61K38/04
Abstract: The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of Formula I as defined herein in combination with paclitaxel, taxotere or modified taxane or taxoid analogs provide enhanced anticancer effects over the effects achieved with the individual compounds.
-
公开(公告)号:DK0758342T3
公开(公告)日:2000-05-01
申请号:DK95917963
申请日:1995-04-26
Applicant: BASF AG
Inventor: BUSCHMANN ERNST , HAUPT ANDREAS , JANSSEN BERND , AMBERG WILHELM , BERNARD HARALD , JANITSCHKE LOTHAR , KARL ULRICH , KLING ANDREAS , M LLER STEFAN , DE POTZOLLI BERND , RITTER KURT , THYES MARCO , ZIERKE THOMAS
Abstract: PCT No. PCT/EP95/01577 Sec. 371 Date Nov. 4, 1996 Sec. 102(e) Date Nov. 4, 1996 PCT Filed Apr. 26, 1995 PCT Pub. No. WO95/30691 PCT Pub. Date Nov. 16, 1995The compound Me2Val-Val-MeVal-Pro-Pro-NHBzlxHCl is described. It is prepared from Z-Val-Val-MeVal-Pro-OR1 where Z and R1 have the meanings stated in the description. The compound shows antineoplastic activity.
-
公开(公告)号:ES2138363T3
公开(公告)日:2000-01-01
申请号:ES96925744
申请日:1996-07-12
Applicant: BASF AG
Inventor: AMBERG WILHELM , BERNARD HARALD , BUSCHMANN ERNST , HAUPT ANDREAS , JANSSEN BERND , ULRICH KARL
IPC: C07K1/02 , C07K1/12 , C07K5/06 , C07K5/078 , C07K5/08 , C07K5/083 , C07K5/10 , C07K5/103 , C07K7/06
Abstract: PCT No. PCT/EP96/03073 Sec. 371 Date Jan. 13, 1998 Sec. 102(e) Date Jan. 13, 1998 PCT Filed Jul. 12, 1996 PCT Pub. No. WO97/05162 PCT Pub. Date Feb. 13, 1997A process for preparing pentapeptides of the formula I where A and R1-R3 have the stated meanings, comprises assembling the pentapeptide stepwise starting from a prolinamide of the formula II where R1 and R2 have the abovementioned meanings, and eliminating the group -NR1R2 by hydrolysis where appropriate the peptide obtained in this way.
-
公开(公告)号:TR9902244T2
公开(公告)日:1999-12-21
申请号:TR9902244
申请日:1998-03-09
Applicant: BASF AG
Inventor: BARLOZZARI TERESA , HAUPT ANDREAS
IPC: A61K38/00 , A61K31/337 , A61K38/07 , A61K38/08 , A61K38/15 , A61P35/00 , C07K5/08 , C07K5/10 , C07K7/00 , A61K38/04
CPC classification number: A61K38/07 , A61K38/08 , A61K31/335 , A61K2300/00
-
公开(公告)号:TR199902244T2
公开(公告)日:1999-12-21
申请号:TR9902244
申请日:1998-03-09
Applicant: BASF AG
Inventor: BARLOZZARI TERESA , HAUPT ANDREAS
IPC: A61K31/337 , A61K38/07 , A61K38/00 , A61K38/08 , A61K38/15 , A61P35/00 , C07K5/08 , C07K5/10 , C07K7/00 , A61K38/04
Abstract: The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of Formula I as defined herein in combination with paclitaxel, taxotere or modified taxane or taxoid analogs provide enhanced anticancer effects over the effects achieved with the individual compounds.
-
-
-
-
-
-
-
-
-